Enliven Therapeutics, Inc. ($ELVN)
Hohl Benjamin โ CHIEF FINANCIAL OFFICER
Shares
6,018
Price
$0.00
Total Value
$0.00
Nearby Earnings
No earnings within 2 weeks of this transaction.
Transaction Details
| Insider | Hohl Benjamin |
|---|---|
| Title | CHIEF FINANCIAL OFFICER |
| Transaction Date | Jun 17, 2026 |
| Expiration Date | Aug 2, 2031 |
| Transaction Code | M Exercise/Conversion |
| Acquired/Disposed | Disposed |
| Security | Stock Option (right to buy) |
| Derivative | Yes |
| Direct/Indirect | Direct |
| Filing Date | Jun 22, 2026 |
| Shares Purchased | 6,018 |
| Price per Share | $0.00 |
| Total Value | $0.00 |
| Shares Owned After | 86,038 |
| Derivative | Derivative |
| Accession Number | 0001882764-26-000005 |
| Document | View SEC Filing |